Newsroom - Page 3

A collaboration between the Dana-Farber Cancer Institute and the fitness tracking company Fitbit will investigate whether weight loss in women diagnosed with breast cancer can stave off recurrence.
A new study found that public understanding of the role of evidence-based care is equally as important as the medical evidence.
Two years after CDC heralded a drop in obesity rates among the youngest children, authors of a new study say it's too soon to declare victory.
The study team previously published research that linked diabetes to elevated rates of certain cancers.
What we're reading, April 27, 2016: Hawaii passes bill to protect transgender patients; childhood obesity has plateaued, not declined; and HHS awards $5 million to Puerto Rico to fight the Zika virus.
An exhaustive analysis of over a 100,000 individuals has confirmed the absence of unbiased association between statin use and a person’s risk of colorectal cancer; however, an inverse relation of risk and cholesterol levels was identified.
Two posters presented at the AMCP Managed Care & Specialty Pharmacy Annual Meeting evaluated opioid misuse and healthcare utilization and cost, as well as a program to flag potential misuse early.
The FDA issued a warning on the SGLT2 inhibitor class in May 2015, but the review by AACE and ACE found that several of the cases involved patients with type 1 disease.
Diabetes Compendium
Oncology Compendium
Reimbursement Compendium
HF Compendium